MLH1 promoter hypermethylation in Bulgarian patients with colorectal cancer

Balkan Journal of Medical Genetics

Volumn 6, Issue 1-2, 2003, Pages 3-8

  Kadiyska, Tanya ^a   Tzancheva, M ^a   Nedin, D ^b   Alexandrova, A ^b   Marinov, M ^b   Kaneva, R ^a   Damyanov, D ^b   Mitev, V ^c   Kremensky, I ^a  

^a UNIVERSITY HOSPITAL ALEXANDROVSKA   (Bulgaria)

^b Queen Giovanna Hospital   (Bulgaria)

^c MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

Author keywords

Colorectal cancer (CRC); Micro satellite instability (MSI); Mismatch repair (MMR); MLH1 (Mut L homologue of E. coli) promoter; MLH1 promoter hypermethylation

Indexed keywords

PROTEIN MLH1; TYPE II SITE SPECIFIC DEOXYRIBONUCLEASE;

ARTICLE; BULGARIA; CANCER DIAGNOSIS; CANCER PATIENT; CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA METHYLATION; FAMILY HISTORY; GENE INACTIVATION; GENE MUTATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MICROSATELLITE INSTABILITY; POLYMERASE CHAIN REACTION; PROMOTER REGION; RESTRICTION MAPPING; SCREENING; TUMOR SUPPRESSOR GENE;

EID: 2942687143     PISSN: 13110160     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Thomas DC, Umar A, Kunkel TA. Microsatellite instability and mismatch repair defects in cancer. Mutat Res 1996; 350(1): 201-205.
2. Modrich P, Lahue R. Mismatch repair in replication fidelity, genetic recombination, and cancer biology. Ann Rev Biochem 1996; 65: 101-133.
3. Marra G, Boland CR. Hereditary nonpolyposis colorectal cancer: the syndrome, the genes, and historical perspectives. J Natl Cancer Inst 1995; 87(15): 1114-1125.
4. Kolodner R. Biochemistry and genetics of eukaryotic mismatch repair. Genes Dev 1996; 10(12): 1433-1442.
5. Kinzler KW, Vogelstein B. Lessons from hereditary colon cancer. Cell 1996; 87(2): 159-170.
6. Eshleman J, Markowitz S. Microsatellite instability in inherited and sporadic neoplasms. Curr Opin Oncol 1995; 7(1): 83-89.
7. Perucho M. Cancer of the microsatellite mutator phenotype Biol Chem 1996; 377(11): 675-684.
8. Lynch HT, Smyrk TC, Watson P, Lanspa SJ, Lynch PM, Cavalieri RJ, Boland CR. Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology 1993; 104(5): 1535-1549.
9. Lynch HT, de la Chapelle A. Genetic susceptibility to non-polyposis colorectal cancer. J Med Genet 1999; 36(11): 801-818.
10. Lothe RA, Peltomaki P, Meling GI, Aaltonen LA, Nystrom-Lahti M, Pylkkanen L, Heimdal K, Andersen TI, Moller P, Rognum TO. Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history. Cancer Res 1993; 53(24): 5849-5852.
11. Kim H, Jen J, Vogelstein B, Hamilton SR. Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. Am J Pathol 1994; 145(1): 148-156.
12. Peltomaki P, de la Chapelle A. Mutations predisposing to hereditary nonpolyposis colorectal cancer. In: Vande Woude GF, Klein G, eds. Advances in Cancer Research. San Diego: Academic Press, 1997; 93-119.
13. Papadopoulos N, Lindblom A. Molecular basis of HNPCC: mutations of MMR genes. Hum Mutat 1997; 10(2): 89-99.
14. Thibodeau SN, French AJ, Roche PC, Cunningham JM, Tester DJ, Lindor NM, Moslein G, Baker SM, Liskay RM, Burgart LJ, Honchel R, Halling KC. Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes. Cancer Res 1996; 56(21): 4836-4840.
15. Borresen AL, Lothe RA, Meling GI, Lystad S, Morrison P, Lipford J, Kane MF, Rognum TO, Kolodner RD. Somatic mutations in the hMSH2 gene in microsatellite unstable colorectal carcinomas. Hum Mol Genet 1995; 4(11): 2065-2072.
16. Bubb VJ, Curtis LJ, Cunningham C, Dunlop MG, Carothers AD, Morris RG, White S, Bird CC, Wyllie AH. Microsatellite instability and the role of hMSH2 in sporadic colorectal cancer. Oncogene 1996; 12(12): 2641-2649.
17. Liu B, Nicolaides NC, Markowitz S, Willson JK, Parsons RE, Jen J, Papadopolous N, Peltomaki P, de la Chapelle A. Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nat Genet 1995; 9(1): 48-55.
18. Wu Y, Nystrom-Lahti M, Osinga J, Looman MW, Peltomaki P, Aalantonen LA, de la Chapelle A, Hofstra RM, Buys CH. MSH2 and MLH1 mutations in sporadic replication error-positive colorectal carcinoma as assessed by two-dimensional DNA electrophoresis. Genes Chrom Cancer 1997; 18(4): 269-278.
19. Herman JG, Merlo A, Mao L, Lapidus RG, Issa JP, Davidson NE, Sidransky D, Baylin SB. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res. 1995; 55(20): 4525-4530.
20. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB, Sidransky D. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1995; 1(7): 686-692.
21. Herman JG, Latif F, Weng Y, Lerman MI, Zbar B, Liu S, Samid D, Duan DS, Gnarra JR, Linehan WM. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci USA 1994; 91(21): 9700-9704.
22. Jones PA, Laird PW. Cancer epigenetics comes of age. Nat Genet 1999; 21(2): 163-167.
23. Kane MF, Loda M, Gaida GM, Lipman J, Mishra R, Goldman H, Jessup JM, Kolodner R. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair defective human tumor cell lines. Cancer Res 1997; 57(5): 808-811.
24. Herman JG, Umar A, Polyak K, Graff JR, Ahuja N, Issa JP, Markowitz S, Willson JK, Hamilton SR, Kinzler KW, Kane MF, Kolodner RD, Vogelstein B, Kunkel TA, Baylin SB. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci USA 1998; 95(12): 6870-6875.
25. Cunningham JM, Christensen ER, Tester DJ, Kim CY, Roche PC, Burgart LJ, Thibodeau SN. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res 1998; 58(15): 3455-3460.
26. Veigl ML, Kasturi L, Olechnowicz J, Ma AH, Lutterbaugh JD, Periyasamy S, Li GM, Drummond J, Modrich PL, Sedwick WD, Markowitz SD. Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers. Proc Natl Acad Sci USA 1998; 95(15): 8698-8702.
27. Nakagawa H, Nuovo GJ, Zervos EE, Martin EW Jr, Salovaara R, Aaltonen LA, de la Chapelle A. Age related hypermethylation of the 5′ region of MLH1 in normal colonic mucosa in associated with microsatellite-unstable colorectal cancer development. Cancer Res 2001; 61(19): 6991-6995.
28. Rodriguez-Bigas MA, Boland CR, Hamilton SR, Henson DE, Jass JR, Khan PM, Lynch H, Perucho M, Smyrk T, Sobin L, Srivastava S. A National Cancer Institute workshop on hereditary nonpolyposis colorectal cancer syndrome: meeting highlights and Bethesda Guidelines. J Natl Cancer Inst 1997; 89(23): 1758-1762.
29. Dietmaier W, Riedlinger W, Kohler A. Detection of microsatellite instability (MSI) and loss of heterozygosity (LOH) in colorectal tumors by fluorescent-based multiplex microsatellite PCR. Biochemica 1999; 2(1): 42-45.
30. Wittekind C, Compton CC, Greene FL, Sobin LH. TNM residual tumor classification revisited. Cancer 2002; 94(9): 2511-2516.
31. Wheeler JMD, Beck NE, Kim HC, Tomilson IP, Mortensen NJ, Bodmer WF. Mechanisms of inactivation of mismatch repair genes in colorectal cancer cell lines: the predominant role of hMLH1. Genetics 1999, 96(18): 10296-10301.
32. Simpkins SB, Bocker T, Swisher EM, Mutch DG, Gersell DG, Gersell DJ, Kovatich AJ, Fishel R, Goodfellow PJ. MLH1 promoter methylation and gene silencing is the primary cause of microsatellite instability in sporadic endometrial cancers. Hum Mol Genet 1999; 8(4): 661-666.
33. Ramchandani S, MacLeod AR, Pinard M, von Hofe E, Szyf M. Inhibition of tumorigenesis by a cytosine-DNA, methyltransferase, antisense oligodeoxynucleotide. Proc Natl Acad Sci USA 1997; 94(2): 684-689.